en
/
sv
About Elicera
Elicera in brief
Board
Team
Advisors
Elicera's history
Immuno-oncology
What is immuno-oncology?
CAR T-cell therapy
Oncolytic virus
Technology
CAR T-cell therapy
Challenges
Mode-of-action
Scientific publications
Pipeline
Pipeline
ELC-301
ELC-401
ELC-201
ELC-100
Clinical trials
Patent portfolio
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
Share issues
Analyst Coverage
News
News
Press Releases
Events
Contact
en
/
sv
News
2026
2025
2024
2023
2022
2021
2020
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jun 24, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics receives ATMP-classification from EMA for oncolytic virus
Non-regulatory Press Release
Read more
Jun 10, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics has been approved for listing on Nasdaq First North Growth Market
Non-regulatory Press Release
Read more
Jun 9, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics' new issue heavily oversubscribed
Non-regulatory Press Release
Read more
Jun 4, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics’ last day to subscribe ahead of the listing at Nasdaq First North Growth Market
Non-regulatory Press Release
Read more
Jun 3, 2021
2021
News
CEO-interview by Nyhetsbyrån Direkt
News
Read more
May 31, 2021
2021
News
Article in "Forskning och framsteg"
News
Read more
May 24, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics’ first day to subscribe ahead of the listing at Nasdaq First North Growth Market
Non-regulatory Press Release
Read more
May 18, 2021
2021
News
Eliceras CEO, Jamal El-Mosleh, recognized on In Vivo’s list of 30 Rising Leaders across the biopharma, medtech and health technology sectors.
News
Read more
May 17, 2021
2021
News
Company presentation at "Aktiedagen Göteborg".
News
Read more
Apr 27, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics files a patent application for the development of the next generation oncolytic viruses
Non-regulatory Press Release
Read more
Apr 15, 2021
2021
Press Release Non-regulatory
Biostock writes about Elicera and CAR T-cells
Non-regulatory Press Release
Read more
Mar 22, 2021
2021
Press Release Non-regulatory
Elicera announces appointment of ATMP specialist Karin Hoogendoorn to the Board
Non-regulatory Press Release
Read more
Jan 11, 2021
2021
News
Elicera recruits CFO
News
Read more
Jan 11, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics recruits CFO
Non-regulatory Press Release
Read more
Jan 8, 2021
2021
Press Release Non-regulatory
Elicera Therapeutics invitation to company presentation (in Swedish)
Non-regulatory Press Release
Read more
Oct 20, 2020
2020
News
Daily Mail writes about Elicera
News
Read more
Oct 5, 2020
2020
News
Elicera Therapeutics completes oversubscribed share issue and secures 13,2 MSEK in financing
News
Read more
Oct 5, 2020
2020
Press Release Non-regulatory
Elicera Therapeutics completes oversubscribed share issue and launches unique immuno-oncology company with focus on CAR T-cells and oncolytic viruses
Non-regulatory Press Release
Read more
Jul 15, 2020
2020
News
Immuno-Oncology News writes about Elicera's CAR T-cell program
News
Read more
Jul 6, 2020
2020
News
Financial Times writes about Elicera
News
Read more
Previous
+ Load more
8 / 9
Sign up for Press Releases
I consent to Elicera Therapeutics storing and using my information to send press releases and financial information by email. Read our
privacy policy
.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By continuing to browse this website you agree to cookies being stored on your device in order to improve the experience and analyze how it is being used. Read more in our
Integrity policy
.
Deny
Accept